Observations placeholder
Osphena
Identifier
027438
Type of Spiritual Experience
Background
A description of the experience
Ospemifene (brand name Osphena produced by Shionogi) is an oral medication indicated for the treatment of dyspareunia – pain during sexual intercourse – encountered by some women, more often in those who are post-menopausal. Ospemifene is a selective estrogen receptor modulator (SERM) acting similarly to an estrogen on the vaginal epithelium, building vaginal wall thickness which in turn reduces the pain associated with dyspareunia. Dyspareunia is most commonly caused by "vulval and vaginal atrophy."[2]
The medication was approved by the FDA in February 2013
On Jul, 27, 2018
1,735 people reported to have side effects when taking Osphena.
Among them, 4 people (0.23%) have Hallucination
Most common side effects by gender *:
female:
Vaginal haemorrhage (vaginal bleeding)
Hot flush (sudden feelings of heat)
Vaginal discharge
Muscle spasms (muscle contraction)
Therapeutic response unexpected
Headache (pain in head)
Drug ineffective
Rash
Weight increased
Vulvovaginal pruritus (vulvovaginal severe itching)
There is no Death reported by people who take Osphena yet. This review analyzes which people have Death with Osphena. It is created by eHealthMe based on reports from FDA, and is updated regularly.